|
RCKTW Rocket Pharmaceuticals 1281895 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-47,594,000.00 |
| Balance Sheet |
|
Current Assets
|
$149,827,000.00 |
|
Assets
|
$285,407,000.00 |
|
Current Liabilities
|
$24,466,000.00 |
|
Liabilities
|
$47,368,000.00 |
|
Equity
|
$238,039,000.00 |
|
Shares Out
|
109123671.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-45,394,000.00 |
|
Investing Cash Flow
|
$17,448,000.00 |
| Market Analysis |
Market Cap
|
$1,091,236.71 |
|
BVPS
|
2.18 |
|
PB
|
0.48 |
|
EPS
|
-0.42 |
|
FCF
|
$-45,487,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:32:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:10 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RCKTW documents filed with the SEC.
RCKTW Filings
Clear
